Description
About the Peptides, IV Therapy, and GLP-1 Certification Course
This fully online, self-paced course delivers the only ACCME-accredited certification training that combines IV therapy, GLP-1 weight loss, and peptide therapy in a single curriculum, jointly provided by Amedco LLC and PracticalCME, LLC. Both an RN or NP and her medical director can take the course for direct certification credit, enabling a wellness practice to onboard its entire clinical team through one program. The course is designed for the clinician launching a wellness, weight loss, IV therapy, or peptide practice, and for the medical director evaluating what services the practice can safely and defensibly offer.
Why This Course is Different: Actively Managed, Fresh Content
Peptides, GLP-1 therapy, and IV wellness are the fastest-moving categories in modern aesthetic and wellness medicine. The FDA Bulks List changes. New peptides reach commercial availability. GLP-1 pipeline readouts (retatrutide, orforglipron, oral semaglutide) update what clinicians need to know for patient conversations. Compounding law and state scope-of-practice rules continue to evolve. Most existing training resources in this vertical were built one, two, or three years ago and have not been updated since.
This course is different in two ways:
- Released fresh in August 2026 with current regulatory, pharmacological, and clinical content as of launch. Not a repackaging of older material.
- Breaking News module updated monthly as the field moves. New FDA approvals, new peptide actions, new pipeline data, new compounding law developments are added to the course as they happen. For a worked example of how the Breaking News module operates, see Dr. Zengo’s October 30, 2026 analysis: Update on the October 30 HHS Peptide Enforcement Discretion Policy: What It Means for Prescribers
All updates are included at no additional charge for two years from your purchase date. Your login retains full access to the current version of every topic throughout that period. For a clinician entering a field that is this dynamic, this is the difference between training that keeps you current and training that goes stale before your first patient visit.
What’s Included in Your Tuition
- Full online course access to all 10 topics (approximately 11.5 hours of structured instruction)
- ACCME double-accredited CME certificate: 11.5 AMA PRA Category 1 Credits™ for physicians (AAPA reciprocity for PAs), 11.5 ANCC contact hours including 6.5 pharmacotherapeutic hours for nurses and nurse practitioners
- Jointly accredited through Amedco LLC and PracticalCME, LLC (Amedco Joint Accreditation Provider Number: 4008163)
- Downloadable syllabus PDFs, patient handouts, consent forms, and documentation templates for all three service lines
- Customizable GLP-1 patient instruction handout for direct use in your practice
- Two years of online course access with all monthly content updates included at no additional charge
- Breaking News module updated monthly with FDA actions, new approvals, and regulatory developments as they happen
Course Curriculum (10 Topics, Approximately 11.5 Hours)
- Topic 1: Stress, Nutrition, and the Unforced Errors Behind Common Symptoms
- Topic 2: Scope, Venue, and the Legal Framework for Nurses, NPs, PAs, and Medical Directors
- Topic 3: Peptides: History and the Compounding Pharmacy Channel
- Topic 4: The Top 20 Peptides: Evidence, Eligibility, and Regulatory Status (including BPC-157, TB-500, Sermorelin, CJC-1295, Ipamorelin, Tesamorelin, GHK-Cu, Thymosin alpha-1, MOTS-c, PT-141, methylene blue, NAD+ and more)
- Topic 5: GLP-1 Weight Loss in Clinical Practice: Semaglutide, Tirzepatide, and the Full Protocol (Wegovy, Zepbound, Ozempic, Mounjaro)
- Topic 6: Emerging Weight-Loss Agents, Including Retatrutide and Oral GLP-1s (orforglipron, oral semaglutide)
- Topic 7: Elective IV Therapy: History, Legal Framework, and Patient Screening
- Topic 8: Elective IV Therapy Done Right: Additives, Compounding, and Administration
- Topic 9: The Medical Director Role, Oversight, and Practice Ownership
- Topic 10: Synthesizing the Services into an Integrated Wellness Practice
- Breaking News: Updated monthly with the latest regulatory and clinical developments
Who Should Take This Course
Registered nurses, nurse practitioners, physician assistants, and physicians serving as medical directors of wellness, weight loss, aesthetic, or IV therapy clinics. The course is designed for clinicians who want evidence-based, vendor-neutral training before offering GLP-1 weight loss, peptide therapy, or IV services, and who need genuine CME credit that counts for licensure, hospital credentialing, and professional liability insurance audits. The dual accreditation (AMA Category 1 and ANCC) allows an entire practice team, from RN through medical director, to earn direct certification credit from the same program.
Who Teaches This Course

Founder and Medical Director, PracticalCME. Board-certified physician and surgeon. 20 years of accredited CME authorship. Active medical director for multiple cash-pay wellness practices operating under current state scope and compounding law. Author of the Beyond Injectables peptide, IV therapy, and GLP-1 curriculum, revised monthly as HHS, FDA, and state board actions require.
About PracticalCME’s Beyond Injectables™ Series
This course is part of PracticalCME’s Beyond Injectables™ suite of fully accredited online CME training for clinicians expanding beyond injectable aesthetics into regenerative, wellness, and non-injectable services. Companion courses include Bio-Identical Hormone Therapy (BHRT) with Saliva Testing, Evidence-Based Weight Loss and GLP-1 Master Course, Neurotransmitter and GI Testing and Treatment, and a new Non-Injectable Aesthetics course arriving in 2027. Each course in the series is taught by a board-certified physician, vendor-neutral, and designed for the same compliance-first standard.
Course Access and Credit Policy
Your login credentials arrive by email within a few hours of order completion once your licensure credentials are verified. You can start the course the same day you register.
Is this really updated monthly, or is that marketing language?
It is genuinely updated monthly. The Breaking News module is reviewed and updated as new FDA approvals, pipeline readouts, Bulks List changes, and compounding law developments occur. The module carries dated entries so you can see what has been added since launch. All updates are included in your two years of access at no additional charge.
Is this course accredited for CME and CE credit?
Yes. The activity is jointly accredited by Amedco LLC and PracticalCME, LLC, and is active for full CME and CE credit through September 1, 2028. Physicians earn 11.5 AMA PRA Category 1 Credits™ (with AAPA reciprocity for physician assistants), and nurses and nurse practitioners earn 11.5 ANCC contact hours including 6.5 pharmacotherapeutic contact hours. This is genuine accreditation, not a certificate of completion or vendor-sponsored training.
Does the ANCC credit count for nurse practitioners?
Yes. ANCC contact hours are accepted by nurse practitioner licensing boards nationwide for NP continuing education requirements, including the pharmacotherapeutic hours required for prescriptive authority renewal in most states. Separate AANP accreditation is not required when ANCC is in place.
Who should take this course?
Registered nurses, nurse practitioners, physician assistants, and physicians serving as medical directors of wellness, weight loss, aesthetic, or IV therapy clinics. It is designed for clinicians who want evidence-based, vendor-neutral training before offering GLP-1 weight loss, peptide therapy, or IV services.
Does the course teach how to prescribe and dose GLP-1 medications?
Yes. The course walks through the full clinical workup, baseline labs, contraindication screening, starting doses, the escalation schedule, dose holds, maintenance dosing, side-effect management, and visit-by-visit patient counseling for semaglutide and tirzepatide, plus the oral GLP-1 options.